| |
| |
|
| Insider
Information: |
Oneill Julie |
| Relationship: |
Director |
| City: |
Cheshire |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
47,756 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$7,808,628 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
47,756 |
|
|
| Total
Value |
$7,808,628 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexion Pharmaceuticals Inc |
ALXN |
EVP. Global Operations |
2018-02-28 |
42,787 |
|
0 |
Premium* |
|
|
Hookipa Pharma Inc. |
HOOK |
Director |
2020-10-21 |
4,969 |
2020-10-21 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HOOK |
Hookipa Pharma Inc. |
Director |
– • – |
2020-10-21 |
4 |
A |
$0.00 |
$0 |
D/D |
4,969 |
4,969 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP. Global Operations |
• – – |
2018-02-28 |
4 |
S |
$118.61 |
$81,366 |
D/D |
(686) |
42,787 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP. Global Operations |
• – – |
2018-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
8,940 |
51,727 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP. Global Operations |
• – – |
2018-02-27 |
4 |
S |
$120.72 |
$113,356 |
D/D |
(939) |
43,473 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP. Global Operations |
• – – |
2018-02-08 |
4 |
S |
$116.31 |
$556,776 |
D/D |
(4,787) |
44,412 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP. Global Operations |
• – – |
2018-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
28,989 |
49,199 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP. Global Operations |
• – – |
2018-02-05 |
4 |
S |
$117.26 |
$248,474 |
D/D |
(2,119) |
20,210 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP. Global Operations |
• – – |
2017-09-05 |
4 |
AS |
$145.64 |
$549,381 |
D/D |
(3,763) |
22,329 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP. Global Operations |
• – – |
2017-08-31 |
4 |
AS |
$142.00 |
$86,904 |
D/D |
(612) |
26,092 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP. Global Operations |
• – – |
2017-08-28 |
4 |
AS |
$140.00 |
$1,562,400 |
D/D |
(11,160) |
26,704 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP. Global Operations |
• – – |
2017-03-02 |
4 |
S |
$133.80 |
$87,104 |
D/D |
(651) |
37,864 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP. Global Operations |
• – – |
2017-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
38,515 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP. Global Operations |
• – – |
2017-02-28 |
4 |
S |
$131.70 |
$87,449 |
D/D |
(664) |
31,015 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP. Global Operations |
• – – |
2017-02-27 |
4 |
S |
$131.20 |
$119,392 |
D/D |
(910) |
31,679 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP. Global Operations |
• – – |
2016-09-02 |
4 |
S |
$126.29 |
$82,089 |
D/D |
(650) |
35,384 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP. Global Operations |
• – – |
2016-03-02 |
4 |
S |
$149.55 |
$97,357 |
D/D |
(651) |
36,034 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP. Global Operations |
• – – |
2016-02-29 |
4 |
S |
$138.91 |
$92,097 |
D/D |
(663) |
36,685 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP. Global Operations |
• – – |
2016-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
7,000 |
37,348 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP. Global Operations |
• – – |
2016-02-08 |
4 |
S |
$138.02 |
$107,419 |
D/D |
(778) |
30,348 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP. Global Operations |
• – – |
2016-02-05 |
4 |
S |
$141.54 |
$297,919 |
D/D |
(2,080) |
31,126 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP. Global Operations |
• – – |
2016-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
11,763 |
33,206 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP. Global Operations |
• – – |
2015-09-02 |
4 |
S |
$171.76 |
$111,129 |
D/D |
(647) |
21,443 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP. Global Operations |
• – – |
2015-03-02 |
4 |
S |
$180.34 |
$1,183,932 |
D/D |
(6,565) |
22,090 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP. Global Operations |
• – – |
2015-02-27 |
4 |
S |
$0.00 |
$0 |
D/D |
(5,100) |
28,655 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP. Global Operations |
• – – |
2015-02-10 |
4 |
S |
$171.15 |
$136,064 |
D/D |
(795) |
23,555 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
